Clinical Trials on Cervical Cancer Stage IB2 in Netherlands

Total 81 results

Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Lymphatic Mapping for Image Guided Radiotherapy in Patients With LACC - a Feasibility Study (LaMA)

Locally Advanced Cervical Cancer

Netherlands
University Medical Center Groningen
Human Genome Sciences Inc.

Completed

Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer

Advanced Cervical Cancer

Netherlands
UMC Utrecht

Completed

Detection of Loco-regional Invasion of Cervical Cancer With 7 Tesla MRI (DETECT)

Cervical Cancer

Netherlands
UMC Utrecht

Withdrawn

The Value of Preoperative Sentinel Lymph Node Mapping by Pelvic MR Lymphangiography and SPECT-CT in Cervical Cancer

Cervical Cancer

Netherlands
The Netherlands Cancer Institute

Terminated

Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F)

Cervical Cancer

Netherlands
Maastricht Radiation Oncology
Amsterdam UMC, location VUmc

Completed

Non-invasive Imaging of Cetuximab-Zr. 89 Uptake Wit PET: a Phase I Trial in Stage IV Cancer Patients (Cetuximab Zr89)

Stage IV Cancer

Netherlands
University Medical Center Groningen
Dutch Cancer Society; ViciniVax B.V

Completed

Vvax001 Cancer Vaccine in (Pre) Malignant Cervical Lesions

Cervical Cancer | CIN 2/3

Netherlands
University Medical Center Groningen

Recruiting

Standard Follow-up Program Cervix Cancer (SFP CERVIX) (SFPCERVIX)

Cervical Cancer Radiation Complications

Netherlands
Leiden University Medical Center
Dutch Cancer Society

Unknown

Sexual Rehabilitation Programme After Radiotherapy for Gynaecological Cancer (SPARC)

Cervical Cancer | Gynecologic Cancer | Endometrial Cancer | Vaginal Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Predicting Outcome in Cervix Carcinoma: a Prospective Study (POCER)

Cervical Cancer

Netherlands, South Africa
UMC Utrecht
Odense University Hospital

Recruiting

MRLinac Boost for Gynecological Cancers if Brachytherapy is Not Feasible (MARGARITA) (MARGARITA)

Cervical Cancer | Gynecologic Cancer

Netherlands, Denmark
Academisch Medisch Centrum - Universiteit van Amsterdam...
Agenus Inc.; Dutch Cancer Society

Not yet recruiting

ImmunoTHerapy Adjacent to Cervical CAncer (ITHACA) Study (ITHACA)

Cervical Cancer

Netherlands
Maastricht Radiation Oncology
Maastricht University Medical Center

Completed

Prediction of Clinical Response and Outcome in Uterine Cervix Cancer

Cervix Cancer

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...
UMC Utrecht

Completed

PDL-1 Targeting in Resectable Oesophageal Cancer (PERFECT)

Esophageal Cancer, Stage II | Esophageal Cancer Stage III

Netherlands
Maastricht Radiation Oncology

Terminated

PET CT With HX4 in Cervix Cancer (HX4-cervix)

Cervix Cancer

Netherlands
Maastricht University

Not yet recruiting

Progressive Web App About Individualized Patient Decision Aid for NSCLC Stage I-II

Lung Cancer Stage I | Lung Cancer Stage II

Netherlands
The Netherlands Cancer Institute
Roche Pharma AG

Completed

Carboplatin-cyclophosphamide Combined With Atezolizumab (PROLOG)

Breast Cancer | Ovarian Cancer | Cervix Cancer | Endometrial Cancer

Netherlands
Radboud University Medical Center
Maastricht University Medical Center; Erasmus Medical Center; Catharina Ziekenhuis... and other collaborators

Recruiting

PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer (PROMOTE)

Endometrial Cancer Recurrent | Endometrial Cancer Stage III | Endometrial Cancer Stage IV

Netherlands
Netherlands Open University
Maastricht University Medical Center; Dutch Cancer Society; Maastro Clinic, The... and other collaborators

Completed

The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients

Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer | Non-Hodgkin Lymphoma | Bladder Cancer | Cervix Cancer | Cancer of Skin | Cancer of Endometrium

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer

Cervical Cancer

Netherlands
Nucletron Operations BV
Factory CRO

Completed

Post Market Clinical Follow-up Study Venezia

Cervical Cancer

Austria, Netherlands, Germany
The Netherlands Cancer Institute
Dutch Cancer Society

Terminated

Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung Metastasis (HALO)

Lung Metastases | Lung Cancer Stage I | Lung Cancer Stage II

Netherlands
ISA Pharmaceuticals
Dutch Cancer Society

Completed

Study of the Therapeutic Vaccine (ISA101/ISA101b) to Treat Advanced or Recurrent Cervical Cancer (CervISA)

Cervical Cancer

Germany, Netherlands, Belgium
European Organisation for Research and Treatment...

Completed

Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer

Cervical Cancer

Norway, Germany, United Kingdom, Sweden, Austria, France, Netherlands
The Netherlands Cancer Institute
AstraZeneca

Active, not recruiting

Olaparib and Radiotherapy in Head and Neck Cancer

Head and Neck Neoplasms | Carcinoma, Squamous Cell | Laryngeal Cancer Stage II | Laryngeal Cancer Stage III

Netherlands
Institut Curie

Completed

Biomarker Evaluation in Advanced Stage Cervical Cancer by an International Working Group. Tumor Stages (1B1 - 4) (BIO-RAIDs)

Cervical Cancer

France, Germany, Netherlands, Romania, Serbia
Comprehensive Cancer Centre The Netherlands
Tilburg University; Netherlands Organisation for Scientific Research

Recruiting

Distress In CErvical Cancer Patients and Partners (DICE)

Quality of Life | Cervical Cancer | Psychological Distress | Survivorship | Psychologic Stress

Netherlands
European Organisation for Research and Treatment...

Unknown

Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer

Cervical Cancer

Netherlands, Belgium, Italy, Spain, France, Austria, Portugal, United Kingdom
Radboud University Medical Center
Johnson & Johnson; Philips Healthcare

Recruiting

Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify TDLN in Early-stage NSCLC (INITIATE)

Early-stage Lung Cancer

Netherlands
European Organisation for Research and Treatment...

Completed

Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer

Cervical Cancer | Endometrial Cancer | Infection | Vaginal Cancer | Perioperative/Postoperative Complications

France, Spain, Belgium, Italy, Netherlands, Austria, Portugal, Germany
Maastricht Radiation Oncology

Not yet recruiting

Re-induction of a Systemic Immune Response in Metastatic or Locally Recurrent Lung Cancer (Re-Induce 2)

Lung Cancer Stage IV

Netherlands
University Hospital, Essen

Recruiting

Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients (NEOpredict)

NSCLC, Stage I | NSCLC Stage II | NSCLC, Stage IIIA

Belgium, Germany, Netherlands
Amsterdam UMC, location VUmc
Boehringer Ingelheim

Recruiting

A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer (SHARP)

Advanced Stage Non-small Cell Lung Cancer

Netherlands
Nij Smellinghe Hosptial

Completed

Study the Usefulness of Bio-impedance Spectroscopy in the Early Assessment of Breast Cancer Related Lymphoedema

Lymphedema | Breast Cancer Stage II | Early Disease Onset

Netherlands
Radboud University Medical Center

Terminated

Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy (IDEAL-VMAT)

Stage III Non-small Cell Lung Cancer | Individualized Radiation Dose Escalation

Netherlands
Amsterdam UMC, location VUmc

Completed

Individualized Nutritional Counselling During Chemotherapy for Colorectal Cancer (COLONUT) (COLONUT)

Stage IV Colorectal Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD)

Stage I-III Non-small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Concurrent Chemo-radiotherapy With Intensity-Modulated Radiation Therapy (IMRT) for Limited Disease Small Cell Lung Cancer (LD-SCLC)

Stage I-III Small Cell Lung Cancer

Netherlands
UMC Utrecht

Unknown

MRI Optimization Study in Stage III NSCLC

Stage III Non-small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer | Stage IV (Oligo-metastases)

Netherlands
University Medical Center Groningen
UMCG Kanker Researchfonds

Recruiting

Early Ageing During Therapy in AYA Cancer Patients

Cervical Cancer | Leukemia | Cancer | Breast Cancer | Hodgkin Lymphoma | Osteosarcoma | Ewing Sarcoma | Testicular Cancer

Netherlands
UMC Utrecht
Center for Translational Molecular Medicine; Dutch Cancer Society; Vrienden UMC...

Recruiting

Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer (i-GO)

Breast Cancer | Breast Neoplasms | Metastatic Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Invasive Ductal Breast Cancer | Invasive Ductal Carcinoma of Female Breast | Adenocarcinoma Breast

Netherlands
Maastricht Radiation Oncology
Maastricht University Medical Center; Zuyderland Medical Centre

Completed

Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression From Real Tumour Growth

Stage IV Non-small Cell Lung Cancer

Netherlands
University Medical Center Groningen
Centre Hospitalier Universitaire de Nice; LungenClinic Grosshansdorf

Recruiting

Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Stage III NSCLC (MRD-LUNG)

Lung Cancer Stage III

France, Germany, Netherlands
The Netherlands Cancer Institute
Merck Sharp & Dohme LLC

Completed

Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer

Fallopian Tube Cancer | Peritoneal Cancer | Ovarian Cancer Stage IV

Netherlands
Leiden University Medical Center
Jessa Hospital; The Netherlands Cancer Institute

Recruiting

Response and Toxicity Prediction by Microbiome Analysis After Concurrent Chemoradiotherapy (Prediction)

Immunotherapy | Non Small Cell Lung Cancer Stage III

Netherlands, Belgium
Maastricht Radiation Oncology
University Medical Center Groningen; The Netherlands Cancer Institute

Completed

Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC (NVALT11)

Non Small Cell Lung Cancer (NSCLC) | Stage III Non-Small Cell Lung Cancer | Radical Treatment

Netherlands
Roswell Park Cancer Institute
Pfizer

Completed

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Clear Cell Sarcoma of the Kidney

United States, Netherlands
The Netherlands Cancer Institute

Recruiting

Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer (CisCon)

Fallopian Tube Carcinoma | Peritoneal Cancer | FIGO Stage III Ovarian Cancer

Netherlands
Leiden University Medical Center
Comprehensive Cancer Centre The Netherlands; Dutch Cancer Society

Active, not recruiting

PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer (PORTEC-4a)

Endometrial Cancer Stage I | Endometrial Cancer Stage II

Netherlands, Germany, Belgium, France, Austria, Czechia, Ireland, Switzerland

Clinical Trials on Cervical Cancer Stage IB2 in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations